10 mgLyophilized powder, single vialProcurement inquiry only $99.00Listed price planning Supplier-listed target specification: 99% (HPLC) Not a lot-specific test result
Patients describe "noticeable" or "significant" energy improvement beginning 2-3 days post-injection, peaking at days 4-5, and gradually declining by day 10-12
Published AOD-9604 research included a 12-week oral study and a 24-week oral study
Our study suggests that a pharmacological agent, of which AG1 may be a lead, will likely alleviate the challenges associated with G6PD deficiency
27(5):384389 Murea M, Freedman BI, Parks JS, Antinozzi PA, Elbein SC, Ma L (2010) Lipotoxicity in diabetic nephropathy: the potential role of fatty acid oxidation
Or folks using GLP-1s to lose weight